Quick Takeaways
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G/A for LEXEO THERAPEUTICS, INC. Common Stock (LXEO).
- Disclosed ownership: 11%.
- Date of event: 30 Sep 2025.
JANUS HENDERSON GROUP PLC - 30 Sep 2025 SCHEDULE 13G/A Report for LEXEO THERAPEUTICS, INC. Common Stock (LXEO)
- Filing Manager
- JANUS HENDERSON GROUP PLC
- Reporting Manager
- JANUS HENDERSON GROUP PLC
- Symbol
- LXEO
- Shares outstanding
- 54,031,212 shares
- Disclosed Ownership
- 6,105,527 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 12:49:19 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 14 Aug 2025
- Next filing
- 08 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JANUS HENDERSON GROUP PLC disclosed 11% ownership in LEXEO THERAPEUTICS, INC. Common Stock (LXEO) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 14 Nov 2025, 12:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 11% | 6,105,527 | 0 | 6,105,527 | Kristin Mariani | Head of North America Compliance, CCO | |
| Janus Henderson Biotech Innovation Master Fund Ltd | 7.6% | 4,076,465 | 0 | 4,076,465 | Kristin Mariani | Head of North America Compliance, CCO |